Research Project
Project Title: |
Phase 2, double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with proliferative lupus nephritis (LN) or immunoglobulin A nephropathy (IgAN) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
Phase 2, double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with proliferative lupus nephritis (LN) or immunoglobulin A nephropathy (IgAN). |
Lead principal investigator(s): |
Olga Baraldi, Bologna Gisella Vischini, Bologna Gaetano La Manna, Bologna |
Co-investigator(s): |
Anita Campus, Bologna Beatrice Claudia Marchegiani, Bologna Dario Roccatello, Turin |
Project Period: |
09/2021 - 12/2025 |
Sponsors: |
Industry |
ClinicalTrials.gov: |
NCT04564339 |
EudraCT Nr.: |
2020-001537-13 |
« Back to research page